Document is current
Any future updates will be listed below
-
Authors
Balcan, Baran
Celik, Yeliz
Thunström, Erik
Glantz, Helena
Strollo, Patrick J.
Redline, Susan
Peker, Yüksel https://orcid.org/0000-0001-9067-6538
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 25 November 2025
Revised: 23 December 2025
Accepted: 9 February 2026
First Online: 20 February 2026
Declarations
:
: All participants provided written informed consent, and the study protocol was approved by the Ethics Committee of the University of Gothenburg (Approval No. 207-05; T744-10; T512-11). The RICCADSA trial was registered with ClinicalTrials.gov (NCT00519597) and FoU i Sverige (VGSKAS-4731).
: PS reports personel fees from Emmi Solutions, Jazz Pharmaceuticals, Itamar Medical, Seperation Design Group, Belluscura, grants and personal fees from ResMed, Inspire Medical Systems, grants from Philips-Respironics, National Football League and PinMed, other from Biologix, outside the submitted work; SR has received consulting fees from E Lilly Inc and Amgen Inc; she receives a stipend for her role as editor for the journal Sleep Health; she is an unpaid Board member for Alliance of Sleep Apnea Partners; she is an unpaid scientific advisor for Apnimed Inc. Her institution received a research grant from Google Inc. YP reports institutional grants from ResMed Foundation. BB, YC, ET and HG have nothing to declare.
